• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人生长激素对老年男性身体成分的影响。

Effects of human growth hormone on body composition in elderly men.

作者信息

Rudman D, Feller A G, Cohn L, Shetty K R, Rudman I W, Draper M W

机构信息

Department of Medicine, Medical College of Wisconsin, Milwaukee.

出版信息

Horm Res. 1991;36 Suppl 1:73-81. doi: 10.1159/000182193.

DOI:10.1159/000182193
PMID:1806490
Abstract

Body composition changes progressively in mid and late adulthood. Lean body mass in men over 50 years old contracts at an average rate of -0.6% per year. Body weight tends to remain stable because of a reciprocal expansion of adipose mass. The shrinkage of the lean body mass reflects the atrophy of skeletal muscles, skin and visceral organs. Because growth hormone causes expansion of the lean body mass and contraction of the adipose mass, and because growth hormone secretion tends to diminish in late adulthood, it has been postulated that geriatric hyposomatotropism is a contributory cause to the body composition changes described above. The authors have tested this hypothesis by recruiting 45 independent men over 61 years old with plasma somatomedin C level below 0.35 U/ml, indicating little or no detectable growth hormone secretion. The 21-month protocol was as follows: baseline period 0-6 months, experimental period 6-18 months and post-experimental period 18-21 months. During the experimental period, 26 men (group I) received approximately 0.03 mg/kg of biosynthetic human growth hormone (hGH) subcutaneously 3 times a week, while 19 men (group II) received no treatment. Plasma somatomedin C was measured monthly. The following outcome variables were measured at 0, 6, 12 and 18 months: lean body mass, adipose mass, skin thickness (dermis plus epidermis), sizes of the liver, spleen and kidneys, the cross sectional areas of ten muscle groups, and bone density at 9 skeletal sites. Lean body mass and adipose mass were also measured at 21 months. In group I, hGH treatment raised the plasma somatomedin C level and maintained it in the range 0.5-1.5 U/ml.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

成年中期和后期身体成分会逐渐发生变化。50岁以上男性的瘦体重平均每年以-0.6%的速度减少。由于脂肪量的相应增加,体重往往保持稳定。瘦体重的减少反映了骨骼肌、皮肤和内脏器官的萎缩。因为生长激素会使瘦体重增加、脂肪量减少,且成年后期生长激素分泌往往会减少,所以有人推测老年期生长激素分泌不足是上述身体成分变化的一个促成因素。作者通过招募45名61岁以上、血浆生长调节素C水平低于0.35 U/ml(表明几乎检测不到生长激素分泌或没有生长激素分泌)的独立男性来验证这一假设。21个月的实验方案如下:基线期0 - 6个月,实验期6 - 18个月,实验后期18 - 21个月。在实验期,26名男性(第一组)每周皮下注射约0.03 mg/kg的生物合成人生长激素(hGH)3次,而19名男性(第二组)不接受治疗。每月测量血浆生长调节素C。在0、6、12和18个月时测量以下结果变量:瘦体重、脂肪量、皮肤厚度(真皮加表皮)、肝脏、脾脏和肾脏的大小、十个肌肉群的横截面积以及9个骨骼部位的骨密度。在21个月时也测量了瘦体重和脂肪量。在第一组中,hGH治疗提高了血浆生长调节素C水平并将其维持在0.5 - 1.5 U/ml的范围内。(摘要截短于250字)

相似文献

1
Effects of human growth hormone on body composition in elderly men.人生长激素对老年男性身体成分的影响。
Horm Res. 1991;36 Suppl 1:73-81. doi: 10.1159/000182193.
2
Effects of human growth hormone in men over 60 years old.
N Engl J Med. 1990 Jul 5;323(1):1-6. doi: 10.1056/NEJM199007053230101.
3
Carpal tunnel syndrome and gynaecomastia during growth hormone treatment of elderly men with low circulating IGF-I concentrations.
Clin Endocrinol (Oxf). 1993 Oct;39(4):417-25. doi: 10.1111/j.1365-2265.1993.tb02388.x.
4
[The beneficial effects of growth hormone replacement therapy on elderly men].[生长激素替代疗法对老年男性的有益作用]
Pol Merkur Lekarski. 1999 Mar;6(33):131-4.
5
Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency.长期生理剂量生长激素(GH)给药的撤药:对成年起病型生长激素缺乏男性骨密度和身体成分的不同影响。
J Clin Endocrinol Metab. 2000 Mar;85(3):970-6. doi: 10.1210/jcem.85.3.6474.
6
Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men.重组人生长激素对老年男性抗阻运动肌肉力量反应的影响。
J Clin Endocrinol Metab. 1994 Nov;79(5):1361-6. doi: 10.1210/jcem.79.5.7525633.
7
Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.长期给予[Nle27]生长激素释放激素-(1-29)-NH2对老年男性和女性的内分泌及代谢影响。
J Clin Endocrinol Metab. 1997 May;82(5):1472-9. doi: 10.1210/jcem.82.5.3943.
8
Growth hormone administration conserves lean body mass during dietary restriction in obese subjects.在肥胖受试者饮食限制期间,给予生长激素可保留瘦体重。
J Clin Endocrinol Metab. 1987 May;64(5):878-83. doi: 10.1210/jcem-64-5-878.
9
The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency.
N Engl J Med. 1989 Dec 28;321(26):1797-803. doi: 10.1056/NEJM198912283212605.
10
Exogenous human growth hormone reduces body fat in obese women.外源性人生长激素可减少肥胖女性的体脂。
Horm Res. 1991;35(1):19-24. doi: 10.1159/000181870.

引用本文的文献

1
Animal protein hydrolysate reduces visceral fat and inhibits insulin resistance and hepatic steatosis in aged mice.动物蛋白水解物可减少老年小鼠的内脏脂肪,并抑制胰岛素抵抗和肝脂肪变性。
Nutr Res Pract. 2024 Feb;18(1):46-61. doi: 10.4162/nrp.2024.18.1.46. Epub 2023 Dec 11.
2
Hormonal and Metabolic Changes of Aging and the Influence of Lifestyle Modifications.衰老的激素和代谢变化以及生活方式改变的影响。
Mayo Clin Proc. 2021 Mar;96(3):788-814. doi: 10.1016/j.mayocp.2020.07.033.
3
Mercury in the human adrenal medulla could contribute to increased plasma noradrenaline in aging.
人类肾上腺髓质中的汞可能导致衰老过程中血浆去甲肾上腺素增加。
Sci Rep. 2021 Feb 3;11(1):2961. doi: 10.1038/s41598-021-82483-y.
4
Optimizing Skeletal Muscle Anabolic Response to Resistance Training in Aging.优化衰老过程中骨骼肌对阻力训练的合成代谢反应
Front Physiol. 2020 Jul 23;11:874. doi: 10.3389/fphys.2020.00874. eCollection 2020.
5
Elemental Analysis of Aging Human Pituitary Glands Implicates Mercury as a Contributor to the Somatopause.对衰老人类脑垂体的元素分析表明,汞是导致生长激素缺乏症的一个因素。
Front Endocrinol (Lausanne). 2019 Jun 26;10:419. doi: 10.3389/fendo.2019.00419. eCollection 2019.
6
Sarcopenia: Aging-Related Loss of Muscle Mass and Function.肌肉减少症:与衰老相关的肌肉质量和功能丧失。
Physiol Rev. 2019 Jan 1;99(1):427-511. doi: 10.1152/physrev.00061.2017.
7
Obesity and related consequences to ageing.肥胖及其与衰老相关的后果。
Age (Dordr). 2016 Feb;38(1):23. doi: 10.1007/s11357-016-9884-3. Epub 2016 Feb 4.
8
Cardiometabolic risks during anabolic hormone supplementation in older men.老年男性在补充合成代谢激素期间的心脏代谢风险。
Obesity (Silver Spring). 2013 May;21(5):968-75. doi: 10.1002/oby.20081.
9
Treating age-related changes in somatotrophic hormones, sleep, and cognition.治疗生长激素、睡眠和认知方面与年龄相关的变化。
Dialogues Clin Neurosci. 2001 Sep;3(3):229-36. doi: 10.31887/DCNS.2001.3.3/mvvitiello.
10
Prepubertal gynecomastia a rare complication of growth hormone therapy.青春期前男性乳房发育症是生长激素治疗的罕见并发症。
Indian J Pediatr. 2010 Apr;77(4):443-4. doi: 10.1007/s12098-010-0012-6. Epub 2010 Feb 8.